NPI: 1003847047 · SPRING HILL, FL 34609 · General Acute Care Hospital · NPI assigned 07/06/2006
Authorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
| Authorized Official | LALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL) |
| NPI Enumeration Date | 07/06/2006 |
Other providers sharing the same authorized official: LALOR, PAULA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 14,607 | $289K |
| 2019 | 54,744 | $812K |
| 2020 | 45,649 | $612K |
| 2021 | 56,535 | $1.31M |
| 2022 | 60,529 | $1.89M |
| 2023 | 29,006 | $939K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 17,884 | 16,183 | $1.37M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 12,658 | 11,117 | $816K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2,481 | 2,236 | $549K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5,370 | 4,948 | $485K |
| 70450 | Computed tomography, head or brain; without contrast material | 2,935 | 2,504 | $363K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,510 | 1,350 | $280K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3,879 | 3,297 | $247K |
| 96361 | Intravenous infusion, hydration; each additional hour | 4,694 | 4,021 | $229K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 2,713 | 2,519 | $190K |
| 36415 | Collection of venous blood by venipuncture | 18,720 | 13,269 | $178K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3,359 | 3,024 | $138K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3,803 | 3,325 | $71K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 3,184 | 2,807 | $63K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2,465 | 1,977 | $57K |
| 80053 | Comprehensive metabolic panel | 14,799 | 11,780 | $56K |
| 72125 | Computed tomography, cervical spine; without contrast material | 808 | 668 | $50K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1,583 | 1,197 | $45K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 6,071 | 5,136 | $41K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 204 | 180 | $35K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1,349 | 1,226 | $34K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 415 | 301 | $30K |
| G0378 | Hospital observation service, per hour | 1,586 | 1,165 | $29K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 4,163 | 3,606 | $27K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3,443 | 3,226 | $23K |
| 81001 | 8,749 | 7,529 | $22K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 499 | 308 | $22K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 417 | 338 | $20K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 540 | 405 | $19K |
| 73630 | 691 | 629 | $16K | |
| 85610 | 4,810 | 4,034 | $15K | |
| 73610 | 592 | 544 | $15K | |
| 86850 | 407 | 360 | $14K | |
| 71045 | Radiologic examination, chest; single view | 5,219 | 4,542 | $13K |
| 71046 | Radiologic examination, chest; 2 views | 2,476 | 2,282 | $13K |
| 73130 | 390 | 364 | $12K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 4,056 | 3,410 | $12K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 291 | 259 | $12K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 494 | 397 | $12K |
| 81003 | 2,562 | 2,294 | $11K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 382 | 341 | $11K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3,972 | 3,637 | $11K |
| J7030 | Infusion, normal saline solution , 1000 cc | 4,257 | 3,253 | $10K |
| 86900 | 994 | 861 | $10K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 15,002 | 11,728 | $9K |
| 73564 | 305 | 261 | $9K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 5,476 | 4,448 | $8K |
| 73110 | 260 | 237 | $8K | |
| 76818 | 90 | 62 | $7K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 694 | 605 | $7K |
| 87070 | 247 | 201 | $7K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 184 | 173 | $6K |
| 84484 | 3,913 | 2,691 | $6K | |
| 59025 | Fetal non-stress test | 262 | 180 | $6K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1,574 | 1,391 | $5K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 265 | 236 | $5K |
| 96375 | Therapeutic injection; each additional sequential IV push | 4,791 | 3,945 | $5K |
| 87807 | 1,656 | 1,576 | $5K | |
| 82962 | 1,111 | 510 | $5K | |
| 84703 | 1,131 | 1,034 | $4K | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 61 | 56 | $4K |
| 85730 | 4,645 | 3,932 | $4K | |
| 87186 | 1,049 | 907 | $4K | |
| 76819 | Fetal biophysical profile; without non-stress testing | 64 | 47 | $4K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 3,790 | 3,033 | $4K |
| 83735 | 5,298 | 4,127 | $3K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 6,663 | 5,737 | $3K |
| 83690 | 4,736 | 4,134 | $3K | |
| 73030 | 178 | 154 | $3K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1,245 | 891 | $3K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 86 | 77 | $3K |
| 74018 | 180 | 165 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 4,216 | 3,452 | $2K |
| 76830 | Ultrasound, transvaginal | 159 | 147 | $2K |
| J2270 | Injection, morphine sulfate, up to 10 mg | 1,186 | 781 | $2K |
| 93971 | 138 | 122 | $2K | |
| 86901 | 1,039 | 904 | $2K | |
| 76801 | 209 | 170 | $1K | |
| 83880 | 1,143 | 958 | $1K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 319 | 283 | $1K |
| 87428 | 1,438 | 1,360 | $1K | |
| 87210 | 236 | 208 | $984.60 | |
| 85379 | 1,266 | 1,111 | $915.96 | |
| 72131 | 29 | 27 | $851.99 | |
| 94760 | 859 | 753 | $761.53 | |
| 87077 | 740 | 640 | $750.61 | |
| 87040 | 1,077 | 798 | $670.57 | |
| 70486 | 12 | 12 | $666.98 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 1,691 | 1,262 | $662.64 |
| 84702 | 1,235 | 982 | $604.99 | |
| 85027 | 1,485 | 1,187 | $601.65 | |
| 82550 | 1,187 | 924 | $518.70 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 154 | 130 | $474.37 |
| 96376 | 710 | 366 | $445.27 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 320 | 284 | $418.42 |
| 82077 | 381 | 324 | $400.15 | |
| 93975 | 13 | 12 | $307.34 | |
| 73080 | 15 | 13 | $305.34 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 67 | 53 | $227.94 |
| 82553 | 485 | 408 | $195.79 | |
| 81025 | 2,514 | 2,211 | $166.26 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 414 | 334 | $164.48 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,076 | 918 | $155.55 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 753 | 620 | $153.47 |
| 94664 | 77 | 68 | $143.50 | |
| 87081 | 2,020 | 1,887 | $104.99 | |
| 87430 | 2,350 | 2,203 | $104.92 | |
| 83605 | 232 | 202 | $95.30 | |
| 84112 | 15 | 12 | $81.08 | |
| 80143 | 126 | 111 | $78.53 | |
| 80179 | 85 | 75 | $78.53 | |
| 86140 | 379 | 322 | $66.83 | |
| 90714 | 14 | 13 | $65.35 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 26 | 25 | $65.35 |
| 72110 | 13 | 12 | $60.64 | |
| 84443 | Thyroid stimulating hormone (TSH) | 344 | 300 | $37.35 |
| J1170 | Injection, hydromorphone, up to 4 mg | 86 | 40 | $21.02 |
| 85651 | 72 | 62 | $8.76 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 450 | 333 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 119 | 104 | $0.00 |
| 82570 | 30 | 25 | $0.00 | |
| 84156 | 29 | 24 | $0.00 | |
| 29125 | 13 | 12 | $0.00 | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | 17 | 15 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 16 | 12 | $0.00 |
| 82150 | 95 | 88 | $0.00 | |
| 73090 | 13 | 12 | $0.00 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 322 | 247 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 16 | 12 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 258 | 199 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 46 | 39 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 119 | 94 | $0.00 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 15 | 13 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 127 | 105 | $0.00 |
| 86308 | 14 | 13 | $0.00 | |
| J7050 | Infusion, normal saline solution, 250 cc | 57 | 27 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 43 | 38 | $0.00 |
| 88304 | 16 | 16 | $0.00 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 20 | 20 | $0.00 |